Abiopharma

Clinical trial NCT03383458 updates: 1. completion date: 2031-02-27 → 2031-05-27 2. primary completion date: 2026-02-27 → 2026-05-27

Clinical trial NCT07581002 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-07-22 → 2026-06-30

Clinical trial NCT07586202: start date: 2026-07-17 → 2026-07-28.

General Announcement: COMPLETION OF DISPOSAL OF CHEMICAL TANKER - MT SINAR MENDAWAI

SEALSQ Launches Commercial Phase of Miraex Quantum Photonics Technology Following Strategic Acquisition

Law Offices of Howard G. Smith Encourages Bloom Energy Corporation (BE) Shareholders To Inquire About Securities Fraud Class Action

Law Offices of Howard G. Smith Encourages Capricor Therapeutics, Inc. (CAPR) Shareholders To Inquire About Securities Fraud Class Action

Hesai Group to Hold 2026 Second Extraordinary General Meeting on August 28, 2026

NewcelX Announces Pricing of $1.4 Million Equity Financing at 20% Premium Pricing

Securities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Continues - Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm